ACCESS THE LATEST RESEARCH AND INSIGHTS
Get Glamorous Returns with This Unassuming Company as it Transitions Back to Growth
Also Inside: An overseas cannabis producer with 150% upside as it feeds demand in Europe and Latin America.
Plus: Why Canadian Western Bank will continue its robust recovery. And Calian Group’s new deals prompt a price target boost.
Get Glamorous Returns with This Unassuming Company as it Transitions Back to Growth
Also Inside: An overseas cannabis producer with 150% upside as it feeds demand in Europe and Latin America.
Plus: Why Canadian Western Bank will continue its robust recovery. And Calian Group’s new deals prompt a price target boost.
This Multi-Royalty Pioneer is Gaining Size and Scale and Pays a Healthy Dividend
Also inside: Why this company is the “hands down leader” in hospital supply chain management and well-positioned to grow revenue and profitability.
Plus, find out how Ag Growth International has positioned itself “brilliantly” to capitalize on the recovery in agriculture.
This Multi-Royalty Pioneer is Gaining Size and Scale and Pays a Healthy Dividend
Also inside: Why this company is the “hands down leader” in hospital supply chain management and well-positioned to grow revenue and profitability.
Plus, find out how Ag Growth International has positioned itself “brilliantly” to capitalize on the recovery in agriculture.
This New Age MTV Could Ride Mobile Video Surge to Big Gains
Also inside: Why this airline can continue its incredible turnaround.
Plus, a cannabis stock setting up for an explosive move.
This New Age MTV Could Ride Mobile Video Surge to Big Gains
Also inside: Why this airline can continue its incredible turnaround.
Plus, a cannabis stock setting up for an explosive move.
Nanotech Security Could Have Mega Gains by Disrupting the Anti-Counterfeiting Sector
Also inside: Why the worst is over for Horizon North Logistics and Calfrac Well Services and how the stocks can gain more than 70%.
Plus, three breakout cannabis stocks from setyourstop.com
Nanotech Security Could Have Mega Gains by Disrupting the Anti-Counterfeiting Sector
Also inside: Why the worst is over for Horizon North Logistics and Calfrac Well Services and how the stocks can gain more than 70%.
Plus, three breakout cannabis stocks from setyourstop.com
How to Consistently Double the Market’s Return
Also inside: New insight on Pacific Insight Electronics. What Ryan Irvine thinks the company should do after getting a second takeover offer.
Plus, research on a financial technology company with 90% upside. And, new coverage of a meal kit company that could give you juicy returns.
How to Consistently Double the Market’s Return
Also inside: New insight on Pacific Insight Electronics. What Ryan Irvine thinks the company should do after getting a second takeover offer.
Plus, research on a financial technology company with 90% upside. And, new coverage of a meal kit company that could give you juicy returns.
This Tour Operator Could More Than Triple as Momentum Builds
Also inside: Get to know VersaBank. This commercial lender has 85% upside.
New coverage of Apotex partner CannTrust Holdings which is developing cannabis-infused coffee. The stock has triple digit potential.
This Tour Operator Could More Than Triple as Momentum Builds
Also inside: Get to know VersaBank. This commercial lender has 85% upside.
New coverage of Apotex partner CannTrust Holdings which is developing cannabis-infused coffee. The stock has triple digit potential.
Why Siyata Mobile is a Big Truckin’ Opportunity!
Philips partner Profound Medical could have more than 200% upside as the CEO builds another winner.
VersaPay’s RBC contract win is just the beginning with the stock set for 50% upside.
How high teens earnings growth can drive Alimentation Couche-Tard to 30% gains.
Why Siyata Mobile is a Big Truckin’ Opportunity!
Philips partner Profound Medical could have more than 200% upside as the CEO builds another winner.
VersaPay’s RBC contract win is just the beginning with the stock set for 50% upside.
How high teens earnings growth can drive Alimentation Couche-Tard to 30% gains.
Why Enbridge is a F#$@&%* Table Pounding Buy
How Jonathan Goodman’s Knight Therapeutics could outperform his previous big success, Paladin Labs.
Why CanniMed is the best-performing cannabis stock right now.
How Avivagen can triple its share price in the next year.
Why Enbridge is a F#$@&%* Table Pounding Buy
How Jonathan Goodman’s Knight Therapeutics could outperform his previous big success, Paladin Labs.
Why CanniMed is the best-performing cannabis stock right now.
How Avivagen can triple its share price in the next year.